The U.S. Food and Drug Administration approved the first drug to combat the second most common type of skin cancer. The drug, tested in San Antonio, has been called 'an oncology breakthrough.'San Antonio Express-News
NEW YORK, September 28, 2018 – Hearst Connecticut Media Group has entered into a content partnership with the Connecticut News Project, Inc.’s The Connecticut Mirror.More News
Hearst Connecticut Media Group is on the ground, helping to ensure this year's 2018 Connecticut Open is a winning match for the community.